Abstract
AbstractType 2 diabetes interferes with bone remodeling mechanisms, requiring studies to reverse this damage, and resveratrol is a polyphenol with rich properties. This study aimed to characterize the long bone morphology and peri-implant biomechanics of normoglycemic and type 2 diabetic animals treated with resveratrol. Thirty-two male Wistar rats were used and divided into normoglycemic and diabetic with or without treatment. They had the installation of implants in the tibia and treatment with oral resveratrol within 45 days. Resveratrol was responsible for weight homeostasis and decreased glycemic levels in rats with type 2 diabetes. The three-point bending testing, resveratrol showed positive effects on the biomechanics of long bones, corroborating a more resistant bone in comparison to untreated diabetics. Micro-ct revealed how bone metabolism is affected by systemic disease, decreasing bone quality. The counter-torque of normoglycemic animals showed superior osseointegration to diabetes, with no differences in the administration of the polyphenol, showing the sovereignty of the deleterious effects of the disease when there is a tissue lesion and an inflammatory picture installed. Overall, resveratrol acted positively in the etiopathogenesis of type 2 diabetes and revealed positive effects on the strength of long bones.
Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Saeedi, P. et al. IDF Diabetes atlas committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 157, 107843. https://doi.org/10.1016/j.diabres.2019.107843 (2019).
2. Diabetes Mellitus fact sheet. World health organization. http://www.who.int/health-topics/diabetes (2002).
3. Silva, A. G. & Lazaretti-Castro, M. Diabetes mellitus, thiazolidinediones, and fractures: An unfinished story. Arq. Bras. Endocrinol. Metabol. 54, 345–351 (2010).
4. Sever, M. D. Bone disease in diabetes mellitus. Brazilian diabetes society. https://diabetes.org.br/diabetes-mellitus-e-saude-ossea/ (2021).
5. Hernandez, C. J. et al. Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. Bone. 37, 825–832 (2005).